rs3764261, None

N. diseases: 26
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
High density lipoprotein measurement
1440 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.800 1.000 22 2008 2019
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
663 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.860 1.000 8 2010 2018
Serum HDL cholesterol measurement
CUI: C0428472
Disease: Serum HDL cholesterol measurement
679 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 8 2008 2013
Serum total cholesterol measurement
CUI: C1445957
Disease: Serum total cholesterol measurement
1243 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.800 1.000 8 2010 2019
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
1418 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.800 1.000 6 2009 2018
Low density lipoprotein cholesterol measurement
1142 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.800 1.000 5 2010 2019
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
591 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.830 1.000 5 2010 2018
Polypoidal choroidal vasculopathy
CUI: C1504336
Disease: Polypoidal choroidal vasculopathy
67 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.040 1.000 4 2013 2018
Serum LDL cholesterol measurement
CUI: C0428474
Disease: Serum LDL cholesterol measurement
555 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 3 2010 2013
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
526 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 1 2015 2015
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
526 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 1 2015 2015
Aortic Aneurysm, Abdominal
CUI: C0162871
Disease: Aortic Aneurysm, Abdominal
90 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1.000 1 2018 2018
Cardiovascular Diseases
CUI: C0007222
Disease: Cardiovascular Diseases
711 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1 2015 2015
Coronary heart disease
CUI: C0010068
Disease: Coronary heart disease
1178 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 1 2011 2011
Diabetes Mellitus, Non-Insulin-Dependent
2672 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1 2015 2015
Dyslipidemias
CUI: C0242339
Disease: Dyslipidemias
184 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1.000 1 2015 2015
Exudative age-related macular degeneration
109 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 1 2015 2015
exudative macular degeneration
CUI: C2237660
Disease: exudative macular degeneration
69 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 1 2015 2015
Glycogen storage disease type II
CUI: C0017921
Disease: Glycogen storage disease type II
269 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1.000 1 2014 2014
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
526 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 1 2015 2015
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
527 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.700 1.000 1 2015 2015
Hypertensive disease
CUI: C0020538
Disease: Hypertensive disease
1085 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1.000 1 2017 2017
Lipids measurement
CUI: C0523744
Disease: Lipids measurement
53 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.800 1.000 1 2012 2012
Myocardial Infarction
CUI: C0027051
Disease: Myocardial Infarction
680 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1.000 1 2014 2014
Obesity
CUI: C0028754
Disease: Obesity
1111 0.732 0.280 16 56959412 upstream gene variant C/A snv 0.31 0.010 1.000 1 2015 2015